Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ongericimab and Toripalimab in Advanced Colorectal Cancer
NCT07106034Phase 2Recruiting
- Sponsor
- Shanghai Pudong Hospital
- Start
- Aug 2025
- Primary completion
- Jul 2027
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ongericimab, toripalimab in colorectal cancer (CRC), sponsored by Shanghai Pudong Hospital. Started Aug 2025; status: recruiting.
02
Drugs
ongericimabtoripalimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07106034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07106034.